Fisher & Paykel Healthcare Corporation LtdShs Aktie 798488 / NZFAPE0001S2
20.20
USD
-0.83
USD
-3.97%
30.10.2024
NASO
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Fisher Paykel Healthcare Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2024 | Fisher & Paykel Healthcare Corporation LtdShs | 1.90 | 0.49 | NZD |
| 2023 | Fisher & Paykel Healthcare Corporation LtdShs | 1.79 | 0.48 | NZD |
| 2022 | Fisher & Paykel Healthcare Corporation LtdShs | 1.91 | 0.46 | NZD |
| 2021 | Fisher & Paykel Healthcare Corporation LtdShs | 1.39 | 0.45 | NZD |
| 2020 | Fisher & Paykel Healthcare Corporation LtdShs | 1.06 | 0.32 | NZD |
| 2019 | Fisher & Paykel Healthcare Corporation LtdShs | 1.74 | 0.27 | NZD |
| 2018 | Fisher & Paykel Healthcare Corporation LtdShs | 1.89 | 0.25 | NZD |
| 2017 | Fisher & Paykel Healthcare Corporation LtdShs | 2.37 | 0.23 | NZD |
| 2016 | Fisher & Paykel Healthcare Corporation LtdShs | 2.00 | 0.20 | NZD |
| 2015 | Fisher & Paykel Healthcare Corporation LtdShs | 2.47 | 0.16 | NZD |
Gewinn je Aktie- Fisher & Paykel Healthcare Corporation LtdShs
| 0.2 24 | 0.4 23 | 0.7 22 | 0.9 21 | 0.5 20 | 0.4 19 | 0.3 18 |
Umsatz je Aktie- Fisher & Paykel Healthcare Corporation LtdShs
| 3.0 24 | 2.7 23 | 2.8 22 | 3.4 21 | 2.2 20 | 1.9 19 | 1.7 18 |
KGV- Fisher & Paykel Healthcare Corporation LtdShs
| 113 24 | 61.6 23 | 37.3 22 | 35.2 21 | 60.7 20 | 43.0 19 | 39.5 18 |
Fisher & Paykel Healthcare Corporation LtdShs: Die Aktie (in NZD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | 0.23 | 0.43 | 0.65 | 0.91 | 0.50 | 0.37 | 0.33 |
| Gewinn je Aktie unverwässert | 0.23 | 0.43 | 0.65 | 0.91 | 0.50 | 0.37 | 0.33 |
| Gewinn je Aktie verwässert | 0.23 | 0.43 | 0.65 | 0.91 | 0.50 | 0.36 | 0.33 |
| Dividende pro Aktie | 0.49 | 0.48 | 0.46 | 0.45 | 0.32 | 0.27 | 0.25 |
| Gesamtdividendenausschüttung in Mio. | 145.50 | 195.70 | 224.90 | 181.30 | 146.40 | 114.60 | 102.50 |
Fisher & Paykel Healthcare Corporation LtdShs: Unternehmenskennzahlen (in NZD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 3.00 | 2.73 | 2.83 | 3.36 | 2.20 | 1.85 | 1.67 |
| KGV (Jahresendkurs, EPS unverwässert) | 112.60 | 61.56 | 37.27 | 35.16 | 60.71 | 42.99 | 39.52 |
| KGV (Jahresendkurs, EPS verwässert) | 113.40 | 61.93 | 37.47 | 35.46 | 61.23 | 43.38 | 40.00 |
| KGV (Jahresendkurs) | 112.60 | 61.56 | 37.27 | 35.16 | 60.71 | 42.99 | 39.52 |
| Dividendenrendite Jahresende in % | 1.90 | 1.79 | 1.91 | 1.39 | 1.06 | 1.74 | 1.89 |
| Eigenkapitalquote in % | 77.10 | 79.54 | 79.72 | 73.30 | 67.86 | 75.68 | 74.28 |
| Fremdkapitalquote in % | 22.90 | 20.46 | 20.28 | 26.70 | 32.14 | 24.32 | 25.72 |
Fisher & Paykel Healthcare Corporation LtdShs: GuV (in Mio. NZD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 1’758.10 | 1’588.60 | 1’642.40 | 1’948.20 | 1’273.40 | 1’072.10 | 964.50 |
| Umsatzveränderung in % | 10.67 | -3.28 | -15.70 | 52.99 | 18.78 | 11.16 | 10.93 |
| Bruttoergebnis vom Umsatz | 1’059.70 | 945.90 | 1’013.40 | 1’222.60 | 845.50 | 717.50 | 634.10 |
| Bruttoergebnisveränderung in % | 12.03 | -6.66 | -17.11 | 44.60 | 17.84 | 13.15 | 12.13 |
| Operatives Ergebnis | 368.70 | 339.70 | 466.30 | 689.30 | 389.00 | 312.70 | 264.10 |
| Veränderung Operatives Ergebnis in % | 8.54 | -27.15 | -32.35 | 77.20 | 24.40 | 18.40 | 25.63 |
| Ergebnis vor Steuern | 235.70 | 328.00 | 504.20 | 718.20 | 370.50 | 286.20 | 262.80 |
| Veränderung Ergebnis vor Steuern in % | -28.14 | -34.95 | -29.80 | 93.85 | 29.45 | 8.90 | 12.58 |
| Ergebnis nach Steuer | 132.60 | 250.30 | 376.90 | 524.20 | 287.30 | 209.20 | 190.20 |
| Veränderung Ergebnis nach Steuer in % | -47.02 | -33.59 | -28.10 | 82.46 | 37.33 | 9.99 | 12.44 |
Fisher & Paykel Healthcare Corporation LtdShs: Bilanz (in Mio. NZD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | 523 | 451 | 427 | 554 | 461 | 294 | 264 |
| Langzeit Gesamtverbindlichk. pro Aktie | 0.24 | 0.28 | 0.21 | 0.22 | 0.22 | 0.19 | 0.15 |
| Eigenkapital | 1’759 | 1’753 | 1’680 | 1’521 | 974 | 913 | 761 |
| Veränderung Eigenkapital in % | 0.33 | 4.39 | 10.44 | 56.18 | 6.64 | 19.94 | 15.08 |
| Bilanzsumme | 2’282 | 2’205 | 2’107 | 2’075 | 1’435 | 1’207 | 1’025 |
| Veränderung Bilanzsumme in % | 3.50 | 4.63 | 1.54 | 44.60 | 18.92 | 17.72 | 16.73 |
Fisher & Paykel Healthcare Corporation LtdShs: Sonstige Angaben (in NZD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 0.23 | 0.43 | 0.65 | 0.91 | 0.50 | 0.37 | 0.33 |
| Veränderung Gewinn je Aktie (unverwässert) in % | -47.38 | -33.74 | -28.44 | 82.43 | 37.02 | 9.34 | 11.71 |
| Gewinn je Aktie (verwässert) | 0.23 | 0.43 | 0.65 | 0.91 | 0.50 | 0.36 | 0.33 |
| Veränderung Gewinn je Aktie (verwässert) in % | -47.43 | -33.78 | -28.22 | 82.45 | 37.11 | 9.67 | 11.86 |
| Anzahl Mitarbeiter | 7’141 | 6’564 | 7’375 | 6’897 | 5’081 | 4’547 | 4’174 |
| Veränderung Anzahl Mitarbeiter in % | 8.79 | -11.00 | 6.93 | 35.74 | 11.74 | 8.94 | 1.51 |
Fisher & Paykel Healthcare Corporation LtdShs Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Fisher & Paykel Healthcare Corporation LtdShs | Quartalszahlen | 21.05.2025 |
| Fisher & Paykel Healthcare Corporation LtdShs | Quartalszahlen | 02.12.2025 |
| Fisher & Paykel Healthcare Corporation LtdShs | Quartalszahlen | 27.05.2026 |
| Fisher & Paykel Healthcare Corporation LtdShs | Quartalszahlen | 01.12.2026 |
Fisher & Paykel Healthcare Corporation LtdShs vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q2 2025 Earnings Release | 27.11.2024 |
| Hauptversammlung | Annual General Meeting | 28.08.2024 |
| Quartalszahlen | Q4 2024 Earnings Release | 27.05.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 28.11.2023 |
| Hauptversammlung | Annual General Meeting | 29.08.2023 |
| Quartalszahlen | Q4 2023 Earnings Release | 25.05.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 28.11.2022 |
| Hauptversammlung | Annual General Meeting | 24.08.2022 |
| Quartalszahlen | Q4 2022 Earnings Release | 25.05.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 24.11.2021 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 93.43 |
| Pinnacle Investment Management Group Ltd. | 6.15 |
| Hyperion Asset Management Ltd. | 6.05 |
| First Sentier Investors (Australia) IM Ltd. | 2.51 |
| First Sentier Invt. ICVC - Stewart Invt Asia Pac. Leaders Sust | 2.41 |
| New Zealand Superannuation Fund | 2.23 |
| Accident Compensation Corp. | 1.56 |
| Government Pension Fund - Global (The) | 1.49 |
| Vanguard Total International Stock Index Fund | 1.37 |
| First Sentier Investors (Hong Kong) Ltd. | 1.16 |
| First Sentier Investors (Singapore) | 1.06 |
| Hyperion Australian Growth Companies Fund (Top 5 Holdings) | 1.04 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 4’174 | 4’547 | 5’081 | 6’897 | 7’375 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.23 | 0.24 | 0.25 | 0.28 | 0.22 |
Bilanz (in Mio. NZD) - Aktiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 424 | 455 | 519 | 920 | 888 |
| Summe Anlagevermögen | 601 | 751 | 916 | 1’155 | 1’219 |
| Summe Aktiva | 1’025 | 1’207 | 1’435 | 2’075 | 2’107 |
Bilanz (in Mio. NZD) - Passiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 264 | 294 | 461 | 554 | 427 |
| Summe Eigenkapital | 761 | 913 | 974 | 1’521 | 1’680 |
| Summe Passiva | 1’025 | 1’207 | 1’435 | 2’075 | 2’107 |
Adresse
| 15 Maurice Paykel Place, 2013 Auckland | |
| Telefon | +64 (9) 574-0100 |
| Fax | +64 (9) 574-0158 |
| URL | http://www.fphcare.com |
Management
|
Andrea Blackie
Deputy Chief Financial Officer |
|
Andrew Mark Cross
Independent Non-Executive Director |
|
Andrew Robert Donald Somervell
Vice President-Products & Technology |
|
Andy Niccol
Chief Operating Officer |
|
Brian Schultz
Vice President-Quality & Regulatory Affairs |
|
Dexter Cheung
Manager-Research & Development |
|
Graham Mclean
Independent Non-Executive Director |
|
Jonti Rhodes
VP-Supply Chain, Facilities & Sustainability |
|
Justin Callahan
Vice President-Sales & Marketing |
|
Karen Knotts
General Manager-Corporate Communications |
|
Lewis George Gradon
Chief Executive Officer, MD & Executive Director |
|
Lisa Margaret McIntyre
Independent Non-Executive Director |
|
Lyndal York
Chief Financial Officer |
|
Marcus Driller
Vice President-Corporate |
|
Michael Grenfell Daniell
Non-Executive Director |
|
Miriam Cather Simpson
Independent Non-Executive Director |
|
Neville J. Mitchell
Chairman |
|
Nicholas Fourie
VP-Information & Communication Technology |
|
Nicola Talbot
Vice President-Human Resources |
|
Philippa Mary Greenwood
Independent Non-Executive Director |
|
Raelene Leonard
Secretary & General Counsel |
|
Winston Fong
Vice President-Surgical Technologies |